Structures by: Seferoğlu Z.
Total: 24
C27H30N4O3S
C27H30N4O3S
New Journal of Chemistry (2020) 44, 44 19155-19165
a=7.6487(14)Å b=8.7524(14)Å c=20.607(3)Å
α=94.791(7)° β=100.141(7)° γ=109.862(7)°
C24H23N3O4S
C24H23N3O4S
New Journal of Chemistry (2020) 44, 44 19155-19165
a=8.0871(5)Å b=8.3785(5)Å c=16.9875(10)Å
α=98.318(3)° β=91.468(3)° γ=105.343(3)°
C23H21N3O3S
C23H21N3O3S
New Journal of Chemistry (2020) 44, 44 19155-19165
a=8.4790(7)Å b=10.8451(8)Å c=12.1470(10)Å
α=75.707(4)° β=89.516(4)° γ=72.029(3)°
3-(4-Chlorophenyldiazenyl)-1-methyl-2-phenyl-1H-indole
C21H16ClN3
Acta Crystallographica Section E (2006) 62, 6 o2108-o2110
a=8.0836(10)Å b=27.952(4)Å c=30.483(3)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-4-(4'-methoxyphenyl)-1,3-thiazole
C10H10N2OS
Acta Crystallographica Section E (2006) 62, 4 o1609-o1611
a=7.181(2)Å b=7.750(2)Å c=17.994(3)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-5-(p-nitrophenylsulfonyl)-1,3-thiazole
C9H7N3O4S2
Acta Crystallographica Section E (2006) 62, 7 o2634-o2636
a=8.6310(2)Å b=12.4943(3)Å c=11.4911(4)Å
α=90.00° β=110.874(2)° γ=90.00°
N-{4-[(2-Phenyl-1H-indol-3-yl)diazenyl]phenyl}acetamide
C22H18N4O
Acta Crystallographica Section E (2006) 62, 8 o3492-o3494
a=5.996(5)Å b=14.786(5)Å c=20.531(5)Å
α=90° β=90° γ=90°
1-Methyl-2-phenyl-3-(thiadiazol-2-yldiazenyl)-1H-indole
C17H13N5S
Acta Crystallographica Section E (2007) 63, 1 o148-o150
a=8.0288(2)Å b=17.3757(3)Å c=11.1899(3)Å
α=90.00° β=104.4222(14)° γ=90.00°
1,2-Dimethyl-3-(thiazol-2-yldiazenyl)-1H-indole
C13H12N4S
Acta Crystallographica Section E (2007) 63, 1 o351-o353
a=8.7257(2)Å b=10.3070(2)Å c=14.4948(6)Å
α=83.828(6)° β=88.489(6)° γ=79.757(5)°
1-Methyl-2-phenyl-3-(5-ethyl-1,3,4-thiadiazol-2-yldiazenyl)-1H-indole
C19H17N5S
Acta Crystallographica Section E (2007) 63, 2 o568-o570
a=10.7629(14)Å b=10.0115(8)Å c=16.568(2)Å
α=90.00° β=99.664(6)° γ=90.00°
6-Amino-1,3-dimethyl-5-(4-methylthiazol-2-yldiazenyl)uracil
C10H12N6O2S
Acta Crystallographica Section E (2007) 63, 2 o571-o573
a=9.3604(3)Å b=10.3052(3)Å c=13.2638(5)Å
α=90.00° β=93.391(2)° γ=90.00°
1-Methyl-3-(5-methylthiazol-2-yldiazenyl)-2-phenyl-1H-indole
C19H16N4S
Acta Crystallographica Section E (2007) 63, 7 o3281-o3282
a=9.2514(7)Å b=9.2745(5)Å c=11.0971(6)Å
α=106.2590(10)° β=106.542(2)° γ=103.337(2)°
1-Methyl-2-phenyl-1H-indole
C15H13N
Acta Crystallographica Section E (2007) 63, 4 o1963-o1964
a=8.19570(10)Å b=15.8652(3)Å c=17.1653(3)Å
α=90.0° β=90.0° γ=90.0°
3-[5,6-Dimethyl-1,3-benzothiazol-2-yl)diazenyl]-1-methyl-2-phenyl- 1<i>H</i>-indole
C24H20N4S
Acta Crystallographica Section E (2007) 63, 7 o3170-o3170
a=13.171(5)Å b=9.815(2)Å c=17.257(4)Å
α=90° β=112.31(2)° γ=90°
C17H15N3O2
C17H15N3O2
Acta Crystallographica Section E (2006) 62, 9 o4130-o4131
a=10.5985(3)Å b=11.2970(2)Å c=12.7652(3)Å
α=90.00° β=107.6970(10)° γ=90.00°
5-[(5-Methylthiazol-2-yl)diazenyl]pyrimidine-2,4,6(1H,3H,5H)-trione
C8H7N5O3S
Acta Crystallographica Section E (2007) 63, 3 o1506-o1508
a=13.092(2)Å b=7.0989(9)Å c=12.913(2)Å
α=90.00° β=116.321(7)° γ=90.00°
3-(6-Methoxybenzothiazol-2-yldiazenyl)-1-methyl-2-phenyl-1<i>H</i>-indole
C23H18N4OS
Acta Crystallographica Section E (2007) 63, 6 o2837-o2839
a=7.3672(2)Å b=17.9326(5)Å c=15.0284(3)Å
α=90.00° β=99.70(2)° γ=90.00°
3-(5-Methylsulfanyl-1,3,4-thiadiazol-2-yldiazenyl)-1,2-methyl-1H-indole
C13H13N5S2
Acta Crystallographica Section E (2007) 63, 5 o2263-o2264
a=7.2739(2)Å b=13.4818(2)Å c=14.7373(4)Å
α=78.488(4)° β=87.707(5)° γ=85.551(5)°
1,3-Dimethyl-5-(thiazol-2-yldiazenyl)pyrimidine-2,4,6(1H,3H,5H)-trione
C9H9N5O3S
Acta Crystallographica Section E (2006) 62, 12 o5855-o5857
a=15.3047(5)Å b=7.4568(2)Å c=19.5403(5)Å
α=90.00° β=92.152(2)° γ=90.00°
Ethyl [2-(2-phenyl-1H-indol-3-yldiazenyl)-1,3-thiazol-4-yl]acetate
C21H18N4O2S
Acta Crystallographica Section E (2006) 62, 9 o3835-o3837
a=10.61110(10)Å b=10.5040(2)Å c=17.3345(2)Å
α=90.00° β=100.2480(10)° γ=90.00°
Ethyl 2-{[(2-phenyl-1H-indol-3-yl)diazenyl]thiazol-4-yl}acetate
C22H20N4O2S
Acta Crystallographica Section E (2006) 62, 12 o5488-o5489
a=9.5545(3)Å b=16.5418(2)Å c=13.1399(3)Å
α=90.00° β=101.07(11)° γ=90.00°
3-(5-Ethyl-1,3,4-thiadiazol-2-yldiazenyl)-1,2-dimethyl-1H-indole
C14H15N5S1
Acta Crystallographica Section E (2007) 63, 5 o2265-o2266
a=8.18790(10)Å b=8.2359(2)Å c=10.5343(3)Å
α=92.560(10)° β=96.66(2)° γ=92.31(3)°
5,6-Diphenylpyrazine-2,3-dicarbonitrile
C18H10N4
Acta Crystallographica Section E (2009) 65, 9 o2225
a=9.2195(2)Å b=7.2837(2)Å c=21.5507(5)Å
α=90.00° β=101.1080(10)° γ=90.00°
3-Phenyldiazenyl-1,2-dimethyl-1<i>H</i>-indole
C16H15N3
Acta Crystallographica Section E (2010) 66, 9 o2311
a=16.3442(3)Å b=10.2713(2)Å c=16.5312(3)Å
α=90° β=104.264(3)° γ=90°